RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Kline to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Kim Kline has written about Drug Resistance, Neoplasm.
Kim Kline
Connection Strength
0.333
Drug Resistance, Neoplasm
  1. Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis. 2006 Oct; 11(10):1813-23.
    View in: PubMed
    Score: 0.245
  2. Tiwary R, Yu W, deGraffenried LA, Sanders BG, Kline K. Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer. Breast Cancer Res. 2011; 13(6):R120.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support